Premium
Intraperitoneal chemotherapy: Hot, timely, and relevant?
Author(s) -
Mackay Helen J.,
Kohn Elise C.
Publication year - 2020
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33163
Subject(s) - medicine , intraperitoneal chemotherapy , chemotherapy , intensive care medicine , standard of care , popularity , randomized controlled trial , oncology , cancer , ovarian cancer , psychology , social psychology
The use of hyperthermic intraperitoneal chemotherapy has been growing in popularity in recent years. Even with a positive randomized trial, issues concerning the study design and the statistical analysis raise questions about whether this technique should be recommended as a standard‐of‐care approach. There are many questions that remain unanswered.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom